NextCure, Inc.NXTCNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank38
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-55.11M
↓ 18% vs avg
Percentile
P38
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-46.72M
Historical baseline
PeriodValueYoY Change
TTM$-55.11M-1.4%
2024$-54.34M+15.0%
2023$-63.95M+10.9%
2022$-71.78M-7.8%
2021$-66.59M-76.1%
2020$-37.81M-8.7%
2019$-34.79M-64.9%
2018$-21.10M-41.0%
2017$-14.97M-